{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:48:01Z","timestamp":1792619281384,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["2022041"],"award-info":[{"award-number":["2022041"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["82104651"],"award-info":[{"award-number":["82104651"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jep.2026.121885","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T15:42:42Z","timestamp":1779550962000},"page":"121885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Traditional Chinese medicine reverses immune checkpoint resistance through lactate metabolic reprogramming in hepatocellular carcinoma: Mechanisms and therapeutic implications"],"prefix":"10.1016","volume":"369","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8005-0770","authenticated-orcid":false,"given":"Lihui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiwen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jep.2026.121885_bib1","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.biotechadv.2014.07.001","article-title":"Verbascoside\u2014A review of its occurrence, (bio)synthesis and pharmacological significance","volume":"32","author":"Alipieva","year":"2014","journal-title":"Biotechnol. Adv."},{"issue":"6","key":"10.1016\/j.jep.2026.121885_bib2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jep.2026.121885_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109124","article-title":"Molecular and cellular basis of the anticancer activity of the prenylated flavonoid icaritin in hepatocellular carcinoma","volume":"325","author":"Bailly","year":"2020","journal-title":"Chemistry\u2013Biological Interact."},{"issue":"5","key":"10.1016\/j.jep.2026.121885_bib4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-Associated lactic acid production blunts tumor immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"issue":"17","key":"10.1016\/j.jep.2026.121885_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18535","article-title":"Luteolin exerts anti-tumour immunity in hepatocellular carcinoma by accelerating CD8+ T lymphocyte infiltration","volume":"28","author":"Cai","year":"2024","journal-title":"J. Cell Mol. Med."},{"issue":"20","key":"10.1016\/j.jep.2026.121885_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202413095","article-title":"Lactylation-driven NUPR1 promotes immunosuppression of tumor-infiltrating macrophages in hepatocellular carcinoma","volume":"12","author":"Cai","year":"2025","journal-title":"Adv. Sci."},{"issue":"4","key":"10.1016\/j.jep.2026.121885_bib7","first-page":"201","article-title":"Displacement of bilirubin from albumin by berberine","volume":"63","author":"Chan","year":"1993","journal-title":"Biol. Neonate"},{"issue":"3","key":"10.1016\/j.jep.2026.121885_bib8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/annonc\/mdv615","article-title":"Regulation of PD-L1: a novel role of pro-survival signalling in cancer","volume":"27","author":"Chen","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jep.2026.121885_bib9","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1136\/gutjnl-2018-315983","article-title":"Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trial","volume":"67","author":"Chen","year":"2018","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.jep.2026.121885_bib10","first-page":"102","article-title":"Dahuang Zhechong pills inhibit liver cancer growth in a mouse model by reversing Treg\/Th1 balance","volume":"20","author":"Chen","year":"2022","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.jep.2026.121885_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115875","article-title":"A UPLC-QTOF\/MS-based hepatic tissue metabolomics approach deciphers the mechanism of Huachansu tablets-based intervention against hepatocellular carcinoma","volume":"239","author":"Chen","year":"2024","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.jep.2026.121885_bib12","volume":"vol. I","year":"2020"},{"key":"10.1016\/j.jep.2026.121885_bib13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"issue":"10088","key":"10.1016\/j.jep.2026.121885_bib14","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","article-title":"Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial","volume":"389","author":"El-Khoueiry","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jep.2026.121885_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12885-019-5471-1","article-title":"First-in-class immune-modulating small molecule icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers","volume":"19","author":"Fan","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.jep.2026.121885_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.32348","article-title":"Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack","volume":"77","author":"Fang","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2026.121885_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12982-015-0037-4","article-title":"Applying the Bradford hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology","volume":"12","author":"Fedak","year":"2015","journal-title":"Emerg. Themes Epidemiol."},{"issue":"7","key":"10.1016\/j.jep.2026.121885_bib18","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.7150\/thno.30787","article-title":"Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics","volume":"9","author":"Feng","year":"2020","journal-title":"Theranostics"},{"issue":"20","key":"10.1016\/j.jep.2026.121885_bib19","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jep.2026.121885_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13020-022-00628-1","article-title":"Metabolomics and integrated network pharmacology analysis reveal SNKAF decoction suppresses cell proliferation and induced cell apoptosis in hepatocellular carcinoma via PI3K\/Akt\/P53\/FoxO signaling axis","volume":"17","author":"Guo","year":"2022","journal-title":"Chin. Med."},{"key":"10.1016\/j.jep.2026.121885_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12943-024-02140-6","article-title":"Artificial intelligence alphafold model for molecular biology and drug discovery: a machine-learning-driven informatics investigation","volume":"23","author":"Guo","year":"2024","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.jep.2026.121885_bib22","doi-asserted-by":"crossref","first-page":"966","DOI":"10.7150\/jca.80456","article-title":"Advances in the mechanism of luteolin against hepatocellular carcinoma based on bioinformatics and network pharmacology","volume":"14","author":"Han","year":"2023","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.jep.2026.121885_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1158\/2326-6066.CIR-18-0481","article-title":"Lactate-mediated acidification of tumor microenvironment induces apoptosis of liver-resident NK cells in colorectal liver metastasis","volume":"7","author":"Harmon","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"18","key":"10.1016\/j.jep.2026.121885_bib24","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1158\/0008-5472.CAN-09-1089","article-title":"Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma","volume":"69","author":"Hoshida","year":"2009","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jep.2026.121885_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1142\/S0192415X20500093","article-title":"Integrating network pharmacology and experimental models to investigate the efficacy of coptidis and Scutellaria containing Huanglian Jiedu decoction on hepatocellular carcinoma","volume":"48","author":"Huang","year":"2019","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.jep.2026.121885_bib26","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jhep.2022.07.018","article-title":"Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B","volume":"77","author":"Ji","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jep.2026.121885_bib27","first-page":"1167","article-title":"Clinical trials on curcumin in relation to its bioavailability and effect on malignant diseases: critical analysis","volume":"396","author":"Khosravi","year":"2023","journal-title":"N. Schmied. Arch. Pharmacol."},{"key":"10.1016\/j.jep.2026.121885_bib28","doi-asserted-by":"crossref","DOI":"10.1177\/2515690X211068826","article-title":"Role of silymarin in cancer treatment: facts, hypotheses, and questions","volume":"27","author":"Koltai","year":"2022","journal-title":"J. Evidence-Based Integrative Med."},{"key":"10.1016\/j.jep.2026.121885_bib29","series-title":"Bencao Gangmu [Compendium of Materia Medica]","author":"Li","year":"1982"},{"key":"10.1016\/j.jep.2026.121885_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ado3485","article-title":"Riplet promotes lipid metabolism changes associated with CD8 T cell exhaustion and anti-PD-1 resistance in hepatocellular carcinoma","volume":"10","author":"Liang","year":"2025","journal-title":"Sci. Immunol."},{"issue":"4","key":"10.1016\/j.jep.2026.121885_bib31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S2095-4964(14)60038-8","article-title":"Three advantages of using traditional Chinese medicine to prevent and treat tumor","volume":"12","author":"Ling","year":"2011","journal-title":"J. Integrat. Med."},{"issue":"12","key":"10.1016\/j.jep.2026.121885_bib32","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1002\/jps.21721","article-title":"Oxidative demethylenation and subsequent glucuronidation are the major metabolic pathways of berberine in rats","volume":"98","author":"Liu","year":"2009","journal-title":"J. Pharmaceut. Sci."},{"issue":"10","key":"10.1016\/j.jep.2026.121885_bib33","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1124\/dmd.110.033936","article-title":"Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats","volume":"38","author":"Liu","year":"2010","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.jep.2026.121885_bib34","article-title":"Research advances in traditional Chinese medicine formulae and active components targeting lipid metabolism for hepatocellular carcinoma therapy","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jep.2026.121885_bib35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","article-title":"Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment","volume":"20","author":"Llovet","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.jep.2026.121885_bib36","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1186\/s12885-020-07447-3","article-title":"Acteoside as a potential therapeutic option for primary hepatocellular carcinoma: a preclinical study","volume":"20","author":"Ma","year":"2020","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.jep.2026.121885_bib37","article-title":"Evidence and possible mechanism of Scutellaria baicalensis and its bioactive compounds for hepatocellular carcinoma treatment","volume":"56","author":"Ma","year":"2024","journal-title":"Ann. Med."},{"key":"10.1016\/j.jep.2026.121885_bib38","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1039\/C9FO01901D","article-title":"Curcumin-enhanced antitumor effects of sorafenib via regulating the metabolism and tumor microenvironment","volume":"11","author":"Man","year":"2020","journal-title":"Food Funct."},{"issue":"1 Suppl. l","key":"10.1016\/j.jep.2026.121885_bib39","doi-asserted-by":"crossref","first-page":"230S","DOI":"10.1093\/ajcn\/81.1.230S","article-title":"Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies","volume":"81","author":"Manach","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"issue":"7","key":"10.1016\/j.jep.2026.121885_bib40","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3390\/antibiotics14070697","article-title":"Multifaceted biological properties of verbascoside\/acteoside: antimicrobial, cytotoxic, anti-inflammatory, and immunomodulatory effects","volume":"14","author":"Mar\u010deti\u0107","year":"2025","journal-title":"Antibiotics"},{"key":"10.1016\/j.jep.2026.121885_bib41","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1583773","article-title":"Bibliometric analysis of network pharmacology in traditional Chinese medicine","volume":"2022","author":"Miao","year":"2022","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"1","key":"10.1016\/j.jep.2026.121885_bib42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12967-024-05011-2","article-title":"The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review","volume":"22","author":"Nie","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jep.2026.121885_bib43","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s12276-025-01415-2","article-title":"Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications","volume":"57","author":"Park","year":"2025","journal-title":"Exp. Mol. Med."},{"issue":"11","key":"10.1016\/j.jep.2026.121885_bib44","first-page":"1067","article-title":"Quasi-irreversible inhibition of CYP2D6 by berberine","volume":"12","author":"Park","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jep.2026.121885_bib45","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.ccell.2023.05.015","article-title":"MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma","volume":"41","author":"Qian","year":"2023","journal-title":"Cancer Cell"},{"issue":"18","key":"10.1016\/j.jep.2026.121885_bib46","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1158\/0008-5472.CAN-14-0319","article-title":"Cell surface lactate receptor GPR81 is crucial for cancer cell survival","volume":"74","author":"Roland","year":"2014","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.jep.2026.121885_bib47","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1158\/2159-8290.CD-19-0074","article-title":"\u03b2-Catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma","volume":"9","author":"Ruiz de Galarreta","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jep.2026.121885_bib48","series-title":"Reconstructed and Annotated by Mori Tateyuki (1845)","article-title":"Circa 200 CE\/1982 edition)","year":"1982"},{"issue":"7","key":"10.1016\/j.jep.2026.121885_bib49","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1002\/ptr.7087","article-title":"Apoptotic effect of compound K in hepatocellular carcinoma cells via inhibition of glycolysis and Akt\/mTOR\/c-Myc signaling","volume":"35","author":"Shin","year":"2021","journal-title":"Phytother Res."},{"issue":"3","key":"10.1016\/j.jep.2026.121885_bib50","first-page":"208","article-title":"Chinese herbal medicine and chemotherapy in the treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials","volume":"8","author":"Shu","year":"2009","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.jep.2026.121885_bib51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12943-025-02378-8","article-title":"The tumor microenvironment in hepatocellular carcinoma: mechanistic insights and therapeutic potential of traditional Chinese medicine","volume":"24","author":"Su","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jep.2026.121885_bib52","article-title":"Xinxiu Bencao [Newly Revised Materia Medica]","author":"Su","year":"1981","journal-title":"Official Tang Dynasty Imper. Pharmacopoeia; Modern Reprint Publ. Anhui Sci. Technol. Press, Hefei"},{"issue":"15 Suppl. l","key":"10.1016\/j.jep.2026.121885_bib53","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1200\/JCO.2021.39.15_suppl.4077","article-title":"A randomized, double-blinded, phase III study of icaritin versus huachashu as the first-line therapy in biomarker-enriched HBV-related advanced hepatocellular carcinoma with poor conditions: interim analysis result","volume":"39","author":"Sun","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.jep.2026.121885_bib54","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.jep.2026.121885_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077969","article-title":"Tissue distribution of berberine and its metabolites after oral administration in rats","volume":"8","author":"Tan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jep.2026.121885_bib56","article-title":"Berberine regulates macrophage polarisation through the inhibition of the Notch1 signalling pathway and the promotion of anti-tumour immunity in hepatocellular carcinoma","volume":"251","author":"Tian","year":"2023","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.jep.2026.121885_bib57","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12906-017-1628-0","article-title":"Prescription frequency and patterns of Chinese herbal medicine for liver cancer patients in Taiwan: a cross-sectional analysis of the national health insurance research database","volume":"17","author":"Ting","year":"2017","journal-title":"BMC Compl. Alternative Med."},{"issue":"3","key":"10.1016\/j.jep.2026.121885_bib58","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.semradonc.2004.04.004","article-title":"Lactate: mirror and motor of tumor malignancy","volume":"14","author":"Walenta","year":"2004","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.jep.2026.121885_bib59","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3389\/fphar.2020.00375","article-title":"Berberine promotes OATP1B1 expression and rosuvastatin uptake by inducing nuclear translocation of FXR and LXR\u03b1","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jep.2026.121885_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118278","article-title":"The mechanism of Xihuang Pills' intervention in the tumour immune microenvironment for the treatment of liver cancer based on the STAT3-PDL1 pathway","volume":"331","author":"Wang","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.jep.2026.121885_bib61","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/17425255.2020.1702022","article-title":"Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations","volume":"16","author":"Weersink","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jep.2026.121885_bib62","doi-asserted-by":"crossref","DOI":"10.2174\/0125899775387801250722064737","article-title":"Exploring compound kushen Injection's anticancer properties in hepatocellular carcinoma: an integrated approach of network pharmacology, bioinformatics, and experimental validation","author":"Wei","year":"2025","journal-title":"Curr. Drug Res. Rev."},{"key":"10.1016\/j.jep.2026.121885_bib63","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.3390\/molecules24101993","article-title":"Quercetin inhibits the proliferation of glycolysis-addicted HCC cells by reducing hexokinase 2 and Akt-mTOR pathway","volume":"24","author":"Wu","year":"2019","journal-title":"Molecules"},{"issue":"13","key":"10.1016\/j.jep.2026.121885_bib64","doi-asserted-by":"crossref","first-page":"6308","DOI":"10.3390\/ijms26136308","article-title":"The therapeutic effect of GPR81 in autoimmune hepatitis and hepatocellular carcinoma via regulating the immune response","volume":"26","author":"Wu","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.jep.2026.121885_bib65","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4254\/wjh.v10.i11.799","article-title":"Role of traditional Chinese medicine in the management of patients with hepatocellular carcinoma","volume":"10","author":"Xi","year":"2020","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.jep.2026.121885_bib66","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18211","article-title":"Integrated analyses for identification of a three-gene signature associated with chaihu shugan san formula for hepatocellular carcinoma treatment","volume":"28","author":"Xing","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.jep.2026.121885_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153722","article-title":"Yangyin Fuzheng Jiedu prescription exerts anti-tumor immunity in hepatocellular carcinoma by alleviating exhausted T cells","volume":"91","author":"Yan","year":"2021","journal-title":"Phytomedicine"},{"issue":"12","key":"10.1016\/j.jep.2026.121885_bib68","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.3109\/00498254.2015.1042537","article-title":"Organic anion-transporting polypeptides contribute to the hepatic uptake of berberine","volume":"45","author":"Yan","year":"2015","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jep.2026.121885_bib69","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3428253","article-title":"Add-on therapy with traditional Chinese medicine improves outcomes and reduces adverse events in hepatocellular carcinoma: a meta-analysis of randomized controlled trials","volume":"2017","author":"Yang","year":"2017","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"5","key":"10.1016\/j.jep.2026.121885_bib70","doi-asserted-by":"crossref","first-page":"178","DOI":"10.31083\/j.fbl2905178","article-title":"Research progress of warburg effect in hepatocellular carcinoma","volume":"29","author":"Yang","year":"2024","journal-title":"Front. Biosci. Landmark"},{"key":"10.1016\/j.jep.2026.121885_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117157","article-title":"Baicalin promotes anti-tumor immunity in hepatocellular carcinoma through HIF-1\u03b1\/Lactate\/CXCL9 axis","volume":"241","author":"Yang","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jep.2026.121885_bib72","first-page":"4083","article-title":"Phase I\/II study of PHY906\/capecitabine in advanced hepatocellular carcinoma","volume":"29","author":"Yen","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jep.2026.121885_bib73","doi-asserted-by":"crossref","DOI":"10.15212\/AMM-2025-0045","article-title":"Artificial intelligence in traditional Chinese medicine: systematic insights from data mining, large language models, and multimodal fusion","volume":"4","author":"Yin","year":"2025","journal-title":"Acta Materia Medica"},{"key":"10.1016\/j.jep.2026.121885_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216824","article-title":"Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming","volume":"589","author":"Yu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jep.2026.121885_bib75","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3560812","article-title":"Systematic review on Chinese herbal medicine induced liver injury","volume":"2016","author":"Zhang","year":"2016","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.jep.2026.121885_bib76","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jep.2026.121885_bib77","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1829346","article-title":"Resveratrol exerts antitumor effects by downregulating CD8+CD122+ tregs in murine hepatocellular carcinoma","volume":"9","author":"Zhang","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jep.2026.121885_bib78","article-title":"Development and validation of a novel immune-metabolic-based classifier for hepatocellular carcinoma","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jep.2026.121885_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113543","article-title":"Bioinformatics and experimental verification to explore the potential mechanism of ginsenoside Rg3 suppresses hepatocellular carcinoma progression","volume":"143","author":"Zhao","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jep.2026.121885_bib80","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jhep.2025.02.045","article-title":"eIF3f promotes tumour malignancy by remodelling fatty acid biosynthesis in hepatocellular carcinoma","volume":"83","author":"Zhou","year":"2025","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.jep.2026.121885_bib81","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S1470-2045(18)30351-6","article-title":"Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial","volume":"19","author":"Zhu","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jep.2026.121885_bib82","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1186\/s12885-024-12438-9","article-title":"Astragaloside IV inhibits cell viability and glycolysis of hepatocellular carcinoma by regulating KAT2A-mediated succinylation of PGAM1","volume":"24","author":"Zhu","year":"2024","journal-title":"BMC Cancer"}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874126007373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874126007373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:08:37Z","timestamp":1783051717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874126007373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":82,"alternative-id":["S0378874126007373"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2026.121885","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traditional Chinese medicine reverses immune checkpoint resistance through lactate metabolic reprogramming in hepatocellular carcinoma: Mechanisms and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2026.121885","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121885"}}